A new study challenges old assumptions by revealing that water on the Moon likely came from multiple sources over billions of years, rather than from a single major deposit long ago.
It was 12 years ago when I posted the first video below of Sarah McLachlan singing what is perhaps her most famous song, “Angel.” I came across it again yesterday and decided to pair it with another version. The first one, recorded in her home studio, shows her well-known ability to go between her “chest voice” (normal range) and “head voice” (high notes, like a falsetto or yodeling). It’s a lovely song, and was written by her and usually performed only with her own piano accompaniment (there are a lot of versions on the Internet). My earlier post describes what the song’s about.
When I looked up the song on Wikipedia, I found this:
On 8 April 2000, McLachlan performed “Angel” with Carlos Santana on guitar at the Pasadena Civic Auditorium in Pasadena, California. The show was televised on Fox TV and released on the DVD Supernatural Live – An Evening with Carlos Santana and Friends.
And of course I hoped that song was on video, too, as I’m a Santana fan. Sure enough, it was, though Santana humbly embroiders the voice and piano with soft accompaniment and a short solo (starts at 2:24). I would have preferred to see him cut loose with an electric solo, but of course it’s not appropriate for this song. Santna’s bit, though, was apparently improvised.
I can’t say that the version with Santana is better than the solo version, but how often do you get to hear two such different musicians play together?
It’s one of the commonplaces that young people who have gender dysphoria (“GD”) will experience both reduced psychiatric problems and reduced suicides if they proceed on to gender reassignment (GR) via “affirmative care”. The suicide claim was dispelled in 2024 by the Finnish investigators given below, who showed that both GD and GR, when compared to controls, do not show increased suicide beyond that predicted from psychiatric problems alone (they used controls). That dispels the common claim by gender activists pushing GR: “Do you want a dead son or a live daughter?” (That’s for transitioning to female gender, but it can be reversed.)
A new paper from the same group, published in Acta Paediatrica, looks not at suicide but psychiatric “morbidity” (psychiatric problems). The study was large, controlled, and takes advantage of the fact that in Finland every doctor visit is recorded for every citizen because of the country’s national health system.
The upshot is simple: children and young people (they used subjects up to 23 years old; henceforth called “subjects”) who sought treatment for GD had significantly more severe psychiatric problems and were referred far more often for “specialist level” treatment than were controls. Those GD subjects were parsed into two groups: those who were given gender reassigment, and those who were not. The conventional wisdom is that if you have GD, then gender reassignment should significantly alleviate their dysphoria, measured by a reduced need for specialist psychiatric treatment.
The conventional wisdom was wrong: gender reassignment didn’t alleviate psychiatric compared to GD people who didn’t get reassignment. The conclusion is that gender reassignment, with its deleterious side effects, was not a good way to improve quality of life, at least measured by the need for psychiatric intervention.
Here’s how the term “gender reassignment” is used in the paper:
Medical GR interventions included masculinising/feminising hormonal treatments, chest masculinisation, and/or genital surgery (vaginoplasty/phalloplasty/metoidioplasty).
These treatments are all irreversible except that removed breasts can be restored by replacements.
Click below to access or download the pdf, or you can see the original paper online here.
As I mentioned, the sample size was large: there were 2,083 GD subjects who presented themselves for treatment, and for each of these subjects the investigators chose eight controls, four males and four females matched to the GD subjects by age and place of residence. The final controls numbered 16,643.
Here are the percentage of subjects who sought specialist-level psychiatric treatment between 2011-2019 (differences from 1996-2010 were in the same direction, but far more people who sought GD treatment had a history of specialized treatment in the later period. The authors don’t know the reason for the rise in GD-associated psychiatric difficulties, but it matches the rise in gender dysphoria in other places, including the U.S.
GD subjects
Sought specialized psychiatric treatment before the presentation for GD (“index date”): 47.9%
Sought specialized psychiatric treatment ≥2 years after the presentation for GD: 61.3%
Controls
Sought specialized psychiatric treatment before the presentation for GD (“index date”): 15.3%
Sought specialized psychiatric treatment ≥2 years after the presentation for GD: 14.2%
This shows that GD subjects, whether or not they went on to GR, initially had about three or more times the rate of psychiatric difficulties than did the controls. That is not new, as GD is generally related to psychiatric difficulties, and it’s likely that some people look for gender reassignment as a way to alleviate their gender dysphoria, or even as a way to alleviate general mental difficulties. But GD subjects in general did not in general show a lessening of psychiatric difficulties after their presentation; in fact, the rate was increased by about 13.4%.
The important figures, though, are those showing whether or not GR treatment alleviated psychiatric difficulties. After all, that is the rationale for gender-reassignment treatment, whether it be hormones or surgery. Here is Table 3 from the paper, with the last two columns being the important ones. They’re divided up by sex, and “GR-” means GD subjects not given gender reassignment, while “GR+” means GD subjects who were given gender reassignment. Click table to enlarge; I’ve put a red rectangle around the area of most importance:
This shows that GD subjects, both those who transitioned to female and those who transitioned towards male, did not have a reduction in psychiatric treatment contact (all contact, whether “specialized” or not) after their transition began or was completed. Au contraire: the psychiatric treatments went up sixfold for those transitioning to female genders and 2.5-fold for those transitioning towards male.
If you look at the third and four data columns, you can see the percentages of GD subjects who got psychiatric treatment for GD but who did not go on to reassignment. Curiously, the psychiatric treatment was more frequent in this group than in the group that went on to reassignment, but only before the data of first consultation for GD.
This difference between the third and fourth and the fifth and sixth data points on the first line is curious. But what’s important here is that there is no marked alleviation of psychiatric contacts for GD subjects who went on to reassignment. They continue to consult psychiatrists, and at about the rate of GD subjects who didn’t go on to reassignment. Again, we don’t see the mitigation of psychiatric difficulties in GD patients that go on to surgery or hormones. Since those procedures have deleterious side effects (anorgasmia and pronounced difficulties after surgery on genitals or even breasts), there is not a strong case to be made for gender reassignment of gender-dyphoric patients, at least in terms of alleviating mental illness.
The first two columns show the data for both male and female controls. Since they didn’t have consultations for GD, the “index date” for controls was given as the date that their matched GD subjects first had a consultation. And, as expected, their psychiatric visits were far less numerous than the GD subjects two years after the index date (though the low levels of consultations for GR+ subjects compared to GR-subjects before the index date is still curious, and I may have missed the authors’ explanation).
This is just a cursory interpretation I’ve made after reading the paper twice, and I may have missed some data that feed into the authors’ conclusion below. What’s clear is that GD is associated with psychiatric disorders, though it may not be causal, and that gender reassignment does not improve mental health compared to dysphoric subjects who didn’t get reassigned. All this suggests that “affirmative care” that puts GD subjects on the path to GR doesn’t, at least in this study, have the salubrious effects that are touted—as measured by the intensity of psychiatric treatment. Gender-reassigned subjects continue to suffer from mental disorders at a rate threefold to fivefold that of controls without gender dysphoria, so GR doesn’t come close to giving subjects the mental stability of controls.
The last paragraph of the paper gives what the authors see as the “Clinical Implications” of their results:
Regardless of gender, adolescents suffering from GD present with excessive psychiatric morbidity. Subsequent to medical GR, psychiatric treatment needs appear to increase. It should be noted that in some individuals, medical GR appears to be linked to deterioration in mental health. Possible mechanisms and vulnerable subgroups should be explored in future studies. The effects of medical GR and the expectations of the patient must be addressed before commencing the treatment. The considerable severe psychiatric morbidity prior to contacting the GIS, and its increase over time, suggest that for some of these adolescents, GD may be secondary to other mental health challenges. This underscores the need to thoroughly assess and appropriately treat mental disorders among those seeking GR before and after undergoing irreversible medical treatments. Psychiatric needs must be adequately met.
h/t: Christopher
Last week I wrote about the possibilities of genetically engineering humans. The quickie version is this – we are already using genetic engineering (CRISPR) for somatic changes to treat diseases, and other applications are likely to follow. Engineering germline cells, which would get into the human gene pool, are legally and ethically fraught, but it’s hard to predict how this will play out. I have also written often about genetically engineering food. I think this is a great technology with many powerful applications, but it should be, and largely is, highly regulated to make sure that anything that gets into the human food chain is safe.
I haven’t written as much about genetically engineering pets, and this is likely to be the lowest hanging fruit. That is because pets are neither food nor are they a human medical intervention. But that does not mean they are not regulated – they are regulated in the US under the FDA and USDA. Genetic engineering is treated as an animal drug, and must be deemed safe to the animals being engineered. The USDA also can regulate engineered plants and animals to make sure they do not pose any risk to the environment, humans, or livestock. This makes sense. We would not want, for example, to allow a company to release a genetically engineered bee, pest, or predator into the environment without proper oversight.
Pets, as a category, are domesticated, are not intended to be used as food, nor are they intended to be released into the wild. I say “intended” because pets can become food for predators, and they can escape or be released into the wild, and even become feral. But these contingencies are much easier to prevent than with food or wild plants or animals. For example, if you get a rescue pet, it has likely already automatically been spade or neutered. One easy way to reduce risk would be to make any GE pet sterile, which is likely what the company would want to do anyway to prevent violation of their patents through breeding. In short, it seems that reasonable regulatory hurdles should not be a major problem for any effort to commercialize GE pets.
Unsurprisingly there are companies already working on this. One company, the Los Angeles Project, is working on making rabbits that glow in the dark. This is actually pretty easy (I bought some glow-in-the-dark petunias last year), as we already have isolated genes for green fluorescent protein and have put them in many types of plants and animals. Another company, Rejuvenate Bio, researches genetic treatments for chronic diseases in humans. This, of course, involves a lot of animal research, so they are also developing these treatments for pets, to increase their health and lifespan. Scoutbio is another company working on gene therapies for disease, but they are focusing on treatments for adults. There are also pet cloning companies, which is not the same thing, but there is a lot of overlap in this technology and it is not a big leap to start tweaking those embryos.
So where is all this likely to lead? First, I think GE pets will happen a lot faster than GE humans, because the ethical and therefore legal bar is likely to be a lot lower. What kinds of modifications are we likely to see? Some we will see simply because it is already possible to do, like the green fluorescent rabbits. We are doing it because we can. But as the tech evolves we can see pets with much longer lifespans. That raises an interesting question – how long would you want your dog or cat to live? Most people I talk to feel that 10-15 years for dogs and 15-20 years for cats is too short. I have owned many pets, and their brief lives always seem to go by too quickly. But at the other end of the spectrum I have also known people who own parrots, which is a lifelong commitment. Also, even though the loss of a pet can be heart-wrenching, you then get to experience a new kind of pet with their own personality and go through the puppy phase again. I also wonder how difficult it would be to lose a beloved pet you owned for 30 years, say. How much harder would that be? There is a sweet spot in there somewhere, perhaps 20-30 years. In any case, it would be interesting to be able to choose the longevity of your pet. And of course, it would be great to reduce the many chronic illnesses that plague our pets.
One other difference between pets and humans is that we have already, through conventional breeding, significantly altered our pets, especially dogs. Just think of all the different dog breeds. Some of them, I would argue, are unethical, like making dog breeds that have difficulty breathing. I seriously think that the institutions that regulate purebred dogs should place a much higher priority on the overall health of any recognized breeds, and not formally recognize any breeds with inherent health problems. It may be too late for this, but that would happen in my perfect world. In fact, genetically engineering pets may improve their overall health and happiness. The compromises that come with breeding cute traits may not be necessary with the power of genetic engineering. We could engineer new traits into baseline healthy and outbred populations, and would not have to use severe genetic restriction to create these extreme breeds.
And of course genetic engineering could create pets that would not otherwise exist. Superficial traits, like eye color and coat pattern, should be easy. Do you want a long hair, short, or wire hair? What color? Short or long tail, straight or curly? Floppy ears or pointy? Non-shedding and hypoallergenic are a must. It would also be possible to engineer their personality – easy to train, family friendly, never bites, etc. We are not far from the age of designer pets. We could also go outside the bounds of existing traits, to make exotic even mythical-seeming pets. This starts to get trickier the more ambitious we get, but is within the realm of possibility.
We could also use genetic engineering to domesticate species that would be difficult to impossible to turn into pets through breeding alone. Most people by now know about the Russian silver foxes bred to be friendly and tame. There is still some controversy about the research – how domesticated are they and did they already have some traits before breeding? But regardless, they do not make good pets. They are difficult to train (they pee everywhere), are destructive, and are very high maintenance. But, with some targeted genetic engineering, it would be easier to give them all the traits we love in dogs, for example. We could do the same possibly with racoons and many other species – GE away their problematic traits and make them easy pets. This starts to get into trickier ethical territory, but at least I would argue that fully domesticating a population of wild animal through genetic engineering is ethically no different than doing it through breeding.
It seems very likely that all of this will happen eventually, with the main question being the timeline. Personally, I have no problem with it, and have to admit I would love an exotic pet – as long as it is properly regulated with the welfare of the animals being adequately considered. In fact, I would like to see a higher standard than currently exists for traditional animal breeding.
My final question, however, is what will eventually be more popular – GE pets or robotic pets. There are interesting arguments to be made for both, and perhaps people will have both, in different contexts and for different purposes. If you could have one or the other right now, in a mature form of the technology (say from 200 years from now), which would you pick? Maybe it won’t matter much because the technologies will both converge on your perfect pet.
The post Genetically Engineered Pets Are Coming first appeared on NeuroLogica Blog.
Today I’m stealing (with permission) the photos of Aussie biologist Scott Ritchie, whose Facebook page is here. And what better subject than kangaroos? Scott’s captions are indented, and you can enlarge his photos by clicking on them.
My last report from my Melbourne to Sydney trip. From Depot Beach in New South Wales. It was epic. Stayed in a National Park cabin that looked out over the ocean. And at 5 o’clock our front lawn became the bar for Eastern Grey Kangaroos [Macropus giganteus]. And in the morning, you could take pictures of the kangaroos watching the sunrise. What could be better for a boy from Iowa?
We had a ring-side seat for roos. There would have been over a dozen here, not including joeys in the pouch:
The boys like a bit of rough and tumble:
They are smart to avoid those claws:
. . . just barely:
Squaring off:
I missed the kick shot. A sudden loud thump. Then the fight was over. One kick!
I don’t know how this is going to work!:
But somehow it does:
White-faced Heron [Egretta novaehollandiae] loves a roo too:
Cute:
Hanging loose:
Don’t trip, mom!:
Just in time for a smoke:
I hate pan pipes!:It’s a tight fit:
Come on big fella. I’m already familied up:Sunrise at Depot Beach:
The answer is: Very likely not, at least not as long as MAHA embraces quackery and antivax pseudoscience—not that that didn't stop STAT News from ignoring the elephant in the room, vaccines, in search of a "kumbaya" moment between MAHA and public health.
The post MAHA and science-based public health: Can’t we all just get along? first appeared on Science-Based Medicine.